日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Repotrectinib in NTRK fusion-positive advanced solid tumors: a phase 1/2 trial

瑞波替尼治疗NTRK融合阳性晚期实体瘤:一项1/2期试验

Besse, Benjamin; Lin, Jessica J; Bazhenova, Lyudmila; Goto, Koichi; de Langen, Adrianus Johannes; Kim, Dong-Wan; Wolf, Jürgen; Springfeld, Christoph; Popat, Sanjay; Lim, Darren W T; Nagasaka, Misako; Hong, Jung Yong; Baik, Christina S; Hervieu, Alice; Moreno, Victor; Yang, Nong; Kollengode, Kanthi; Yang, Haisu; Xu, Yuanfang; Calvet, Christophe Y; Yuan, Yong; Hammell, Amy B; Drilon, Alexander; Solomon, Benjamin J

Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium

RET 改变实体瘤中选择性 RET 抑制剂耐药的基因组机制图谱:RETregistry 全球联盟分析

Waliany, Sarah; Cooper, Alissa J; Liu, Stephen V; Gautschi, Oliver; Rotow, Julia K; Smith, Katherine Emilie Rhoades; Weber, Urs M; Lee, Dae Ho; Loong, Herbert H F; Patel, Jyoti D; Pennell, Nathan A; Nagasaka, Misako; Patel, Shetal A; Tan, Daniel S W; Solomon, Benjamin J; Kim, Tae Min; Pall, Georg; Riess, Jonathan W; Sun, Lova; Früh, Martin; Uy, Natalie F; Gadgeel, Shirish; Feng, Jamie; Do, Andrew; Falcon, Christina; Leighl, Natasha B; Baik, Christina S; Lai, Gillianne G Y; Ou, S Ignatius; Cheung, Kingsley S Y; Patil, Tejas; Mansfield, Aaron S; Weiler, Daniela; Yeap, Beow Y; Wirth, Lori J; Gainor, Justin F; Drilon, Alexander; Lin, Jessica J

Clinicogenomic Characteristics and Treatment Outcomes of Patients With Advanced ALK-Rearranged Squamous and Adenosquamous Non-Small Cell Lung Cancers

晚期ALK重排鳞状细胞癌和腺鳞状细胞癌患者的临床基因组特征和治疗结果

Miao, Emily A; Yeap, Beow; Daher, Sameh; Lomibao, Meghanne; Sun, Fangdi; Keogh, Rachel; Lambden, Jason; Reyes, Amanda; Peterson, Jennifer L; Liang, Joyce; Liu, Audrey; Do, Andrew; Lee, Carrie; Hsu, Melinda; Evangelist, Makenzi; Reuss, Joshua; Gadgeel, Shirish M; Lee, Matthew; Patil, Tejas; Lam, Vincent; Neal, Joel W; Drilon, Alexander; Lin, Jessica J

Dual targeting of RET and SRC synergizes in RET fusion-positive cancer cells

RET 和 SRC 双重靶向治疗对 RET 融合阳性癌细胞具有协同作用。

Son, Juhyeon; Remsing Rix, Lily L; Fang, Bin; Welsh, Eric A; Bremer, Nicole V; Foglizzo, Valentina; Roa, Paola; Sigcha-Coello, Nickole; Liao, Yi; Haura, Eric B; Drilon, Alexander; Koomen, John M; Cocco, Emiliano; Rix, Uwe

ALK Inhibitor Response in Novel ZFPM2::ALK and TRIM24::ALK Fusion-Positive Lung Cancers: Case Report

ALK抑制剂对新型ZFPM2::ALK和TRIM24::ALK融合阳性肺癌的反应:病例报告

Hsu, Charles; Yakoub, Mohamed; Offin, Michael; Eng, Juliana; Drilon, Alexander; Yang, Soo-Ryum

Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer

Zenocutuzumab治疗NRG1融合阳性癌症的疗效

Schram, Alison M; Goto, Koichi; Kim, Dong-Wan; Macarulla, Teresa; Hollebecque, Antoine; O'Reilly, Eileen M; Ou, Sai-Hong Ignatius; Rodon, Jordi; Rha, Sun Young; Nishino, Kazumi; Duruisseaux, Michaël; Park, Joon Oh; Neuzillet, Cindy; Liu, Stephen V; Weinberg, Benjamin A; Cleary, James M; Calvo, Emiliano; Umemoto, Kumiko; Nagasaka, Misako; Springfeld, Christoph; Bekaii-Saab, Tanios; O'Kane, Grainne M; Opdam, Frans; Reiss, Kim A; Joe, Andrew K; Wasserman, Ernesto; Stalbovskaya, Viktoriya; Ford, Jim; Adeyemi, Shola; Jain, Lokesh; Jauhari, Shekeab; Drilon, Alexander

Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancer: Final Safety and Efficacy, Including Overall Survival, From the LIBRETTO-001 Phase I/II Trial

Selpercatinib治疗RET融合阳性非小细胞肺癌:LIBRETTO-001 I/II期试验的最终安全性和有效性,包括总生存期

Gautschi, Oliver; Park, Keunchil; Solomon, Benjamin J; Tomasini, Pascale; Loong, Herbert H; De Braud, Filippo; Goto, Koichi; Peterson, Patrick; Barker, Scott; Liming, Katherine; Oxnard, Geoffrey R; Frimodt-Moller, Bente; Drilon, Alexander

Pan-Cancer Analysis of Oncogenic MET Fusions Reveals Distinct Pathogenomic Subsets with Differential Sensitivity to MET-Targeted Therapy.

对致癌MET融合基因的泛癌分析揭示了对MET靶向治疗具有不同敏感性的不同致病基因组亚群

Febres-Aldana Christopher A, Vojnic Morana, Odintsov Igor, Zhang Tom, Cheng Ryan, Beach Catherine Z, Lu Daniel, Mattar Marissa S, Gazzo Andrea M, Gili Leo, Harshan Manju, Ameri Ali, Machnicki Stephen, Xiao Xiuying, Lockwood William W, Zhou Xiao-Yan, Yao Qianlan, Drilon Alexander, Rekhtman Natasha, Shah Nameeta, Li Anqi, Liu Zebing, Yang Soo-Ryum, Davare Monika A, Ladanyi Marc, Somwar Romel

Next-Generation Sequencing for HLA Genotype Screening and Matching to HLA-Restricted Therapies

用于HLA基因型筛查和HLA限制性疗法匹配的下一代测序

Gormally, Michael V; Chen, Monica F; Noronha, Anne Marie; Panageas, Kristalla; Reynolds, Maggie; Kohlasch, Kaelyn; Novak, Bryan; Kee-Velez, Tatiana; Clarke, Nikeysha; Eubank, Michael; Chu, Cynthia; Wilhelm, Clare; Blouin, Amanda; Kyi, Chrisann; Friedman, Claire; Rudin, Charles M; Kris, Mark G; Shah, Ronak; Aggen, David; D'Angelo, Sandra; Shoushtari, Alexander N; Berger, Michael F; Bandlamudi, Chaitanya; Klebanoff, Christopher A; Drilon, Alexander; Schoenfeld, Adam J; Donoghue, Mark T A

Genetic Ancestry-Based Differences in Biomarker-Based Eligibility for Precision Oncology Therapies

基于遗传祖先的差异对基于生物标志物的精准肿瘤治疗资格的影响

Arora, Kanika; Suehnholz, Sarah P; Zhang, Hongxin; Ostrovnaya, Irina; Kundra, Ritika; Nandakumar, Subhiksha; Nissan, Moriah H; Brannon, A Rose; Bandlamudi, Chaitanya; Ladanyi, Marc; Drilon, Alexander; Brown, Carol L; Solit, David B; Schultz, Nikolaus; Berger, Michael F; Chakravarty, Debyani